NEW YORK (GenomeWeb News) – Atossa Genetics on Thursday priced its initial public offering of 800,000 shares at $5 per share, raising gross proceeds of $4 million.

The Seattle-based firm granted its underwriter a 45-day option to purchase up to 120,000 shares to cover any overallotments. Atossa began trading on the Nasdaq Capital Market on Thursday under ticker symbol "ATOS." Its shares closed down 4 percent on Thursday at $4.80.

Dawson James Securities is the sole book-running manager on the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.